Additionally, Fig. 6 provides an overview of the potential applicability of the proposed radiomics imaging biomarkers in informing treatment strategies for NSCLC, particularly in therapy with EGFR-TKIs or ICIs. Here, EGFR is linked to non-small cell lung carcinoma.